Treatment of rheumatoid arthritis (RA) with monoclonal anti-tumor necrosis factor α antibody (anti-TNFα mAb) results in an accumulation of TH1 CD4+ T cells in the peripheral blood.

被引:0
|
作者
Maurice, MM
van der Graaft, WL
Leow, A
Breedveld, FC
van Lier, RAW
Verweij, CL
机构
[1] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands
[2] Red Cross Blood Transfus Serv, Cent Lab, Dept Clin Viroimmunol, Amsterdam, Netherlands
[3] Univ Amsterdam, Expt & Clin Immunol Lab, Amsterdam, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
798
引用
收藏
页码:S165 / S165
页数:1
相关论文
共 50 条
  • [1] Treatment with monoclonal anti-tumor necrosis factor α antibody results in an accumulation of Th1CD4+T cells in the peripheral blood of patients with rheumatoid arthritis
    Maurice, MM
    van der Graaff, WL
    Leow, A
    Breedveld, FC
    van Lier, RAW
    Verweij, CL
    ARTHRITIS AND RHEUMATISM, 1999, 42 (10): : 2166 - 2173
  • [2] Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells
    Meednu, Nida
    Barnard, Jennifer
    Callahan, Kelly
    Coca, Andreea
    Marston, Bethany
    Thiele, Ralf
    Tabechian, Darren
    Bolster, Marcy
    Curtis, Jeffrey
    Mackay, Meggan
    Graf, Jonathan
    Keating, Richard
    Smith, Edwin
    Boyle, Karen
    Keyes-Elstein, Lynette
    Welch, Beverly
    Goldmuntz, Ellen
    Anolik, Jennifer H.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (02) : 200 - 211
  • [3] Defective Th1 immune response in the peripheral blood from patients with active rheumatoid arthritis (RA): Possible contribution to tuberculosis during anti-TNF treatment
    Kawashima, M
    Miossec, P
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S58 - S58
  • [4] Defective Th1 immune response in the peripheral blood from patients with active rheumatoid arthritis (RA): Possible contribution to tuberculosis during anti-TNF treatment
    Kawashima, M
    Miossec, P
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 113 - 113
  • [5] Chimeric anti-tumor necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy
    Kavanaugh, A
    St Clair, EW
    McCune, WJ
    Braakman, T
    Lipsky, P
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (04) : 841 - 850
  • [6] THE IMPORTANCE OF DOSE AND DOSING REGIMEN OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)
    CHOY, EHS
    PITZALIS, C
    BIJL, JA
    KINGSLEY, GH
    PANAYI, GS
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S129 - S129
  • [7] Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis
    Tak, PP
    Taylor, PC
    Breedveld, FC
    Smeets, TJM
    Daha, MR
    Kluin, PM
    Meinders, AE
    Maini, RN
    ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1077 - 1081
  • [8] Distinct Effects of Anti-Tumor Necrosis Factor Combined Therapy on TH1/TH2 Balance in Rheumatoid Arthritis Patients
    Herman, S.
    Zurgil, N.
    Machlav, S.
    Shinberg, A.
    Langevitz, P.
    Ehrenfeld, M.
    Deutsch, M.
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (07) : 1077 - 1082
  • [9] PD-1hiCXCR5-CD4+T Peripheral Helper Cells Enrich in Rheumatoid Arthritis and Predict Clinical Response to Anti-TNF Treatment
    Ho, Wanki
    Zhu, Huaqun
    Ye, Hua
    Fu, Dongdong
    Xu, Xi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1008 - 1011
  • [10] Anti-tumor necrosis factor (TNF) treatment decreases apoptosis of gut epithelial cells: A novel mechanism of anti-TNF therapy in experimental Crohn's disease (CD)
    Marini, M
    Rivera-Nieves, J
    Sicher, KJ
    Weber, BD
    Bamias, G
    Shealy, D
    Matsumoto, S
    Pizarro, TT
    Cominelli, F
    GASTROENTEROLOGY, 2001, 120 (05) : A314 - A314